Comments on: Skyhawk Therapeutics Has Advanced to the Multiple Ascending Dose Portion of its Phase 1 Study evaluating SKY-0515, a RNA-Targeting Small Molecule for Huntington’s Disease

Comments on: Skyhawk Therapeutics Has Advanced to the Multiple Ascending Dose Portion of its Phase 1 Study evaluating SKY-0515, a RNA-Targeting Small Molecule for Huntington’s Disease https://9krapalm.com/skyhawk-therapeutics-has-advanced-to-the-multiple-ascending-dose-portion-of-its-phase-1-study-evaluating-sky-0515-a-rna-targeting-small-molecule-for-huntingtons-disease/ เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm Wed, 28 Feb 2024 13:49:46 +0000 hourly 1 https://wordpress.org/?v=7.0.2